Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederdrugs.com
Drugs.com - New Drug Approvals
Get the latest updates from Drugs.com - New Drug Approvals directly as they happen.
Follow now 76 followers
Latest posts
Last updated 1 day ago
FDA Approves Yuvezzi (carbachol and brimonidine tartrate) Ophthalmic Solution to Treat Presbyopia
3 days ago
LONDON, U.K. and SEATTLE, Wash., January 28, 2026 – Tenpoint Therapeutics, Ltd...
Darzalex Faspro-Based Quadruplet Regimen Approved for Newly Diagnosed Patients with Multiple Myeloma who are Transplant Ineligible
4 days ago
HORSHAM, Pa., January 27, 2026 – Johnson & Johnson (NYSE:JNJ) announced today...
MannKind Announces FDA Approval of Updated Afrezza Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy
5 days ago
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) --...
Organon Announces US FDA Approval of Supplemental New Drug Application Extending Duration of Use of Nexplanon (etonogestrel implant) for Up to Five Years
15 days ago
JERSEY CITY, N.J.--(BUSINESS WIRE) January 16, 2026 -- Organon (NYSE: OGN), a...
FDA Approves Zycubo (copper histidinate) for Children With Menkes Disease
17 days ago
Solana Beach, CA – JANUARY 13, 2026 – Sentynl Therapeutics Inc. (“Sentynl”)...
FDA Approves Zycubo (copper histidinate) for Children With Menkes Disease
18 days ago
January 12, 2026 -- The U.S. Food and Drug Administration today approved...
FDA Approves Nereus (tradipitant) for the Prevention of Motion Sickness
about 1 month ago
WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)...
FDA Approves Yartemlea (narsoplimab-wuug) for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
about 1 month ago
SEATTLE--(BUSINESS WIRE)--Dec. 24, 2025-- Omeros Corporation (NASDAQ: OMER) today announced that the...
FDA Approves Aqvesme (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
about 1 month ago
CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq...
FDA Approves Furoscix for Use in Pediatric Patients Weighing 43kg or Above
about 1 month ago
WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., December 23, 2025 (GLOBE NEWSWIRE) --...
FDA Approves Cablivi (caplacizumab-yhdp) for Acquired Thrombotic Thrombocytopenic Purpura in Pediatric Patients 12 Years and Older
about 1 month ago
On Dec. 23, 2025, the U.S. Food and Drug Administration approved Cablivi...
FDA Approves Nufymco (ranibizumab-leyk), an Interchangeable Biosimilar to Lucentis
about 1 month ago
Planegg-Martinsried, Germany - December 23, 2025 – Formycon AG (FWB: FYB, Prime...